Herpesvirus DNA polymerases are prototypes for a-like DNA polymerases and important targets for antiherpesvirus drugs. We have investigated changes in the catalytic subunit of herpes simplex virus DNA polymerase following DNA binding by using the techniques of endogeneous fluorescence quenching and limited proteolysis. The fluorescence studies revealed a reduction in the rate of quenching by acrylamide in the presence of DNA without changes in the wavelength of the emission peak or in the lifetime of the fluorophore, consistent with the possibility of conformational changes. Strikngly, the proteolysis studies revealed that binding to a variety of natural and synthetic DNA and RNA molecules induced the appearance of a new cleavage site for trpsin near residue 1060 of the protein and increased cleavage by trypsin near the center of the protein. The extent of these cleavages correlated with the affminty of the polymerase for these ligands. These data provide strong evidence that binding to nucleic acid polymers induces substantial localized conformational changes in the polymerase. The locations of enhanced tryptic cleavage near sites implicated in substrate recognition and interaction with a processivity factor suggest that the conformational changes are important for catalysis and processivity of this prototype a-like DNA polymerase. Inhibition of these changes may provide a mechanism for antiherpesvirus drug.
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A prerequisite of DNA replication is the interaction of DNA polymerase with DNA. Much of what has been learned about DNA polymerases in general, and their binding to DNA in particular, is derived from studies of Escherichia coli DNA polymerase I (Pol I). X-ray crystallography of the large proteolytic (Klenow) fragment of Pol I has shown that its C-terminal polymerase domain possesses a binding cleft that could accommodate a double-stranded B-DNA helix, whereas the N-terminal 3'-5'-exonuclease domain can independently bind single-stranded DNA (1) (2) (3) . These crystallographic analyses, combined with genetic and biochemical studies, have greatly enhanced our knowledge about this enzyme (4) (5) (6) (7) (8) (9) (10) . However, little has been published regarding changes in Pol I upon DNA binding other than a few changes in side chains in contact with single-stranded DNA (3) .
Aside from Pol I and its relatives, the other major class of DNA polymerases is the a-like class (also known as class B), which includes the eukaryotic replicative polymerases (11, 12) . The DNA polymerase encoded by herpes simplex virus (HSV Pol) serves as an excellent prototype of the a-like polymerases in that it is amenable to genetic, pharmacological, and biochemical study, and much information has been obtained regarding functional sites on this molecule (reviewed in ref. 13 ). Herpesviruses are important pathogens, especially in immunocompromised patients such as those with AIDS, and herpesvirus polymerases such as HSV Pol are important targets for antiviral drugs such as acyclovir (reviewed in ref. 14) . Information about these enzymes may aid in further drug development. Little is known about the mechanisms involved in DNA binding of a-like polymerases such as HSV Pol, but sequence homology and modeling exercises have suggested that DNA binding by diverse polymerases might occur in a fashion similar to that of Pol I (15) . Support for this idea has come from the recent crystal structure of human immunodeficiency virus (HIV) reverse transcriptase (16) , which like Pol I has a large cleft that could accommodate double-stranded nucleic acids.
Conformational changes in proteins are frequently critical for function and/or regulation (17) ; for example, a conformational change is important in the mechanism of Pol I fidelity (8) . We have looked for conformational changes in HSV Pol upon binding to DNA, using spectroscopic and proteolytic techniques. The spectroscopic approach relies upon the endogenous fluorescence of HSV Pol, which is due to the presence of nine tryptophan residues (18, 19) , and the use of acrylamide, which quenches tryptophan fluorescence of proteins by physical contact with an excited indole ring. Acrylamide quenching depends on the accessibility of the tryptophans to the acrylamide; therefore, acrylamide quenching can be a useful indicator of protein conformational changes (20) .
Susceptibility to proteolysis can also yield valuable information about conformational changes, again by monitoring differences in accessibility of the protein to a probe, in this case a protease (21 
MATERIALS AND METHODS
Materials. The catalytic subunit of HSV Pol was purified from recombinant baculovirus BP58-infected Sf9 cells (22) by a procedure to be described elsewhere (K.W., A.A.K., C. B. C. Hwang, and D.M.C., unpublished work). Antibod-ies EX6, EX1051, EX3, BGG4, and PP5 have been described (23, 24) . Activated calf thymus DNA (Sigma) was purified (25) 40 ,ug/ml for 2 min on ice, whereas V8 protease digestion was terminated by leupeptin at 0.5 1kg/ml. Samples were subjected to SDS/PAGE (29) .
Gels were either Coomassie-or silver-stained (30) or proteins were transferred to Immobilon-P membranes (31) . Membranes were probed with antibodies by using the ProtoBlot Western blot alkaline phosphatase system (Promega) for detection orwere directly stained in 0.1% Coomassie brilliant blue/50%o methanol. Proteolytic fragments were prepared for sequencing as outlined by Matsudaira (32) 
RESULTS
Probing Conformational Changes in HSV Pol by Fluorometrc Measurements. The background corrected fluorescence emission spectrum of HSV Pol revealed an emission maximum (Ak = 340 nm) that was blue-shifted relative to that of free L-tryptophan (Amkx = 350 nm) under the same conditions. This can be ascribed to shielding of one or more of the tryptophan residues from the aqueous phase by the threedimensional structure of the enzyme (20) . Addition of activated calf thymus DNA at 30 ,g/ml decreased the quantum (dA)5oo-p(dT)10o12 before trypsin digestion, however, the pattern offragments changed, dependent upon the concentration of ligand (Fig. 3A, lanes 4-7) . With increasing DNA concentration, the N-terminal 80-kDa fragment decreased, as did the 50-kDa C-terminal fragment. In contrast, the amount of the 72-kDa N-terminal fragment increased and a new fragment of 43 kDa was observed. The amount of 12-kDa fragment remained relatively unchanged (the modest decrease seen in Fig. 3A was not reproducible (dA)200, (rA)200, (dA)5oo-p(dT)1o12, (rA)5oo0p(dT)j0, activated calf thymus DNA, single-stranded M13mpl8, RF M13mpl8, and A HindIll fragments all gave rise to qualitatively similar changes (Fig. 3B) . However, the extent of change depended greatly on the nucleic acid used. For example, 5 pug of single-stranded M13mpl8 DNA led to a complete disappearance of the 80-kDa fragment and the appearance of substantial amounts of the new 43-kDa fragment (lane 9), whereas 50 ,ug of RF (closed circular double-stranded) M13mpl8 DNA led to very little change in pattern (lane 10), compared with no DNA. To determine whether this correlated with the binding affinity of HSV Pol for these nucleic acids, the ability of each ligand to compete with 1 ng of a labeled 96-bp EcoRI-BamHI fragment was measured. The concentration ofeach ligand that could block 50%o ofthe binding ofthe 96-bp fragment is shown at the bottom of Fig. 3B . There was a strong correlation between binding affinity as measured in the competition assay and the extent of change in the digestion pattern.
Mapping of Sites of Cleavage Following DNA Binding. To determine the locations of the proteolytic cleavage sites that changed upon binding to DNA, we used region-specific antibodies and peptide sequencing to map the tryptic frag- 72-kDa fragments were amino acid 42, the N terminus of the 50-kDa fragment was amino acid 693, and the N terminus of the 12-kDa fragment was amino acid 1120. As was true in the absence of DNA (data not shown), the 72-kDa fragment reacted with antibody EX1051, but less strongly than did the 80-kDa fragment (Fig. 4) . This places the C terminus of the 72-kDa fragment between residues 597 and 685; if the C terminus of the 80-kDa fragment is residue 693, the size difference between the 80-and 72-kDa fragments predicts that DNA binding increases trypsin cleavage near residue 620.
The 43-kDa product that was observed only in the presence of DNA failed to react with EX6, EX1051, or EX3 antiserum but did react with antisera BGG4 and PP5 (Fig. 4) . This result showed that the 43-kDa product lay within the C-terminal half of HSV Pol (Fig. 2) . This was confirmed by peptide sequencing, which revealed that the N terminus of the 43-kDa fragment, like that of the 50-kDa fragment, was residue 693. This location and the size of the fragment predict a C terminus near residue 1060. DISCUSSION Changes in Fluorescence Quenching Suggest a Conformational Change. Acrylamide quenches the fluorescence of tryptophan(s) in HSV Pol by a collisional process as evidenced by the temperature dependence of the quenching constants, Ksv(eff) (Fig. 1) . The linear Stern-Volmer plots indicate both that the fluorescing tryptophan residues differ only slightly in accessibility and that kq(eff) is a quantitative measure of the accessibility of the tryptophans to quencher. The rate of acrylamide quenching was slower in the presence of DNA; thus, the accessibility of the tryptophans is decreased. There are two possible explanations for this decrease due to DNA binding: (i) the fluorescing residues are shielded from collision with acrylamide directly by the binding of DNA or (ii) the binding causes a conformational change resulting in decreased exposure of some of the fluorescing residues (20) . Arguing against the first explanation is our finding that addition of DNA decreased the quantum yield of HSV Pol but did not affect the fluorescence lifetime. This indicates that DNA is bound by a static process-i.e., ground-state binding (27) -such that tryptophans involved in DNA binding are no longer fluorescent. Thus, any remaining fluorescence would be due to tryptophans some distance from the DNA. Therefore, the decrease in the accessibility of these tryptophan residues to quencher upon DNA binding suggests conformational changes in the enzyme (probably local rather than global, since Ama, remained constant and the Stern-Volmer plot remained linear). This would be analogous to the report of Philips et al. (34) , who used acrylamide quenching to detect conformational changes in human adenosine deaminase upon ground-state inhibitor binding.
Changes in Trypsin Cleavage Confirm the Conformatinnal Change and Laze It. It is difficult to imagine how DNA binding could increase the accessibility of trypsin to a given cleavage site without a conformational change in the protein.
Indeed, one of the sites observed in the presence of DNA, which led to the 43-kDa fragment, was not observed at all in its absence, which indicates an enormous increase in the accessibility of that site.
The proteolysis studies indicate where certain conformational changes occur. The results make clear that DNA binding does not cause a global change in the conformation of HSV Pol, because accessibility to the cleavage site that gives rise to the 12-kDa fragment did not meaningfully change and because no change was observed in the pattern of digestion by V8 protease. The tryptic cleavage sites whose accessibility increases map near residues 620 and 1060. This indicates that conformational changes upon DNA binding occur near these residues but does not rule out the possibility that changes occur elsewhere in the molecule.
Little has been published regarding conformational changes in DNA polymerases upon binding to DNA. DNA binding prevents subtilisin inactivation of catalytic activities of Pol I during the preparation of Klenow fragment (35) ; however, this may be due to protection of cleavage sites by DNA rather than conformational changes.
Implication for DNA Binding. The locations of the sites of trypsin cleavage that change upon DNA binding suggest that DNA binds within the C-terminal half of HSV Pol. This suggestion, which is attractive because there are data that implicate this region in polymerase activity (reviewed in refs. 13 and 14) , has been confirmed (K.W., A.A.K., and D.M.C., unpublished results). One would also expect nucleic acid contacts within the N-terminal half of the molecule, which has been hypothesized to harbor the RNase H and 3'-5'-exonuclease activities (22, (36) (37) (38) ; indeed, we have detected DNA binding by this half of the molecule as well (K.W., A.A.K., and D.M.C., unpublished results).
It has been hypothesized (15, 36, 39 ) that a-like DNA polymerases such as HSV Pol might be analogous to the Klenow fragment of E. coli Pol I, in which the C-terminal polymerase domain binds the double-stranded region of primer-template while the N-terminal 3'-5'-exonuclease domain can bind single-stranded DNA independently. If this hypothesis were correct, one might predict single-stranded DNA to elicit different conformational changes than DNAs containing double-stranded regions. However, not only did single-stranded DNAs elicit similar changes to doublestranded DNAs, but they did so more efficiently, concomitant with higher affinities for HSV Pol (Fig. 3B ). This would be consistent with evidence suggesting that 3'-5'-exonuclease and polymerase domains of HSV Pol and other a-like DNA polymerases are not as structurally and functionally independent as those of Pol I and its relatives (refs. 40-42 and K.W., A.A.K., C. B .C. Hwang, and D.M.C., unpublished work).
We also found that RNA-containing nucleic acids bound to HSV Pol (Fig. 3B and unpublished results) . This in itselfis not surprising given the intrinsic RNase H activity of HSV Pol (22, 37) . What was somewhat surprising was that RNAcontaining molecules, even poly(rA), elicited changes that were indistinguishable from those elicited by DNA. We can imagine two possible interpretations of this finding: (i) either binding of RNA to the RNase H site of HSV Pol, which is thought to be in the N-terminal half of the molecule, elicits a conformational change in the C-terminal half ofthe molecule, suggesting functional interdependence of different portions ofthe enzyme, or (ii) RNA can bind directly to the C-terminal Biochemistry: Weisshart et 
Implications for Polymerase Mechanisms and Antiviral Drugs. The site in the center of HSV Pol whose accessibility increases upon DNA binding is near or within regions A and II of sequence homology shared among a-like DNA polymerases. Mutations that confer altered sensitivity to nucleoside analogs map within these regions, implicating them directly or indirectly in dNTP recognition (reviewed in refs. 13 and 14) . Our best guess for the location of the site is within region A (residues 577-637), which is shared among certain viral and cellular DNA polymerases (14, 43) . However, from the limited resolution of our analysis, the site may be adjacent to region II (residues 694-736), which has been proposed to directly interact with dNTPs (43) on the basis of several altered drug-sensitivity mutations mapping therein. This region also contains a highly conserved aspartic residue that is thought to be involved in catalysis in diverse polymerases (15, 16 DNA once it is bound to the cleft in the C-terminal domain (5) , for which there is now x-ray crystallographic evidence (L. Beese and T. Steitz, personal communication). In this regard, it is interesting that residues -1080-1140 are predicted to be hydrophilic and flexible (23, 39) .
Alternatively, this C-terminal domain or the regions near the center of the protein may move at certain stages of the catalytic cycle, as has been proposed for the "thumb" subdomains of Pol I and HIV reverse transcriptase (15, 16) . Indeed, the anti-HIV drug nevirapine, which binds to a site between different subdomains of HIV reverse transcriptase, has been proposed to act by preventing such a conformational change (16) . We suspect that the conformational changes we have detected in HSV Pol are critical for the functioning of this enzyme and can envision the development of antiviral drugs that could act by binding to herpesvirus DNA polymerases and interfering with such changes.
